Vanguard Group Inc Biotechnology

Vanguard Group Inc

$5.57 Trillion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
BTAI Bio Xcel Therapeutics, Inc.	$59.4M	$439,000 0.0% of portfolio	1,187,466	Q4 2024 Reduced 1.16%
ARMP Armata Pharmaceuticals, Inc.	$57.1M	$433,000 0.0% of portfolio	234,119	Q4 2024 Added 3.92%
ACXP Acurx Pharmaceuticals, Inc.	$4.51M	$428,000 0.0% of portfolio	529,349	Q3 2024 Added 7.66%
AIM Aim Immuno Tech Inc.	$5.77M	$397,000 0.0% of portfolio	1,988,704	Q4 2022 Added 0.06%
INAB In8 Bio, Inc.	$4.9M	$384,000 0.0% of portfolio	1,423,897	Q1 2024 Added 241.71%
LYRA Lyra Therapeutics, Inc.	$4.46M	$375,000 0.0% of portfolio	1,787,422	Q4 2024 Added 0.46%
GANX Gain Therapeutics, Inc.	$22.5M	$361,000 0.0% of portfolio	177,075	Q4 2024 Added 21.94%
SPRB Spruce Biosciences, Inc.	$7.07M	$345,000 0.0% of portfolio	843,844	Q3 2024 Reduced 2.26%
PMCB Pharma Cyte Biotech, Inc.	$27.4M	$300,000 0.0% of portfolio	192,387	Q2 2024 Added 10.19%
SNSE Sensei Biotherapeutics, Inc.	$15.7M	$297,000 0.0% of portfolio	594,454	Q4 2024 Reduced 3.93%
LEXX Lexaria Bioscience Corp.	$10.2M	$268,000 0.0% of portfolio	127,433	Q4 2024 Added 16.89%
ANEB Anebulo Pharmaceuticals, Inc.	$35.6M	$258,000 0.0% of portfolio	154,036	Q3 2024 Added 0.11%
CVAC Cure Vac N.V.	$559M	$244,000 0.0% of portfolio	71,768	Q3 2024 Reduced 47.55%
PHVS Pharvaris N.V.	$534M	$244,000 0.0% of portfolio	12,740	Q3 2024 New
INDP Indaptus Therapeutics, Inc.	$4.87M	$217,000 0.0% of portfolio	256,265	Q4 2023 Added 2.2%
RNXT Renovo Rx, Inc.	$9.07M	$202,000 0.0% of portfolio	141,487	Q4 2024 Added 149.37%
INKT Mi Nk Therapeutics, Inc.	$305M	$156,000 0.0% of portfolio	234,182	Q3 2023 Reduced 2.9%
TPST Tempest Therapeutics, Inc.	$8.02M	$148,000 0.0% of portfolio	176,193	Q4 2023 Reduced 17.01%
VINC Vincerx Pharma, Inc.	$11.4M	$77,000 0.0% of portfolio	286,372	Q4 2024 Reduced 54.36%
RPTX Repare Therapeutics Inc.	$44M	$71,000 0.0% of portfolio	54,265	Q4 2024 Reduced 1.51%
EYEN Eyenovia, Inc.	$38.7M	$65,000 0.0% of portfolio	438,313	Q4 2024 Reduced 76.7%
VIRX Viracta Therapeutics, Inc.	$751K	$46,000 0.0% of portfolio	289,174	Q4 2024 Reduced 69.7%
ONVO Organovo Holdings, Inc.	$21M	$42,000 0.0% of portfolio	114,640	Q4 2024 Reduced 67.01%
BRTX Bio Restorative Therapies, Inc.	$6.61M	$28,000 0.0% of portfolio	20,472	Q1 2024 Reduced 83.03%
HCWB Hcw Biologics Inc.	$10.7M	$16,000 0.0% of portfolio	37,677	Q2 2024 Added 0.07%
SILO Silo Pharma, Inc.	$3.92M	$14,000 0.0% of portfolio	16,334	Q4 2023 Added 12.62%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	3,464,952	Q4 2024 Added 3.45%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.